These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 28687404)

  • 1. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
    Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
    Miao N; Zheng H; Sun X; Zhang G; Wang F
    Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seroepidemiological analysis of hepatitis B among children aged 1-14 in 3 counties of Guangdong province in 2013].
    Shao X; Wu C; Wang F; Liang J; Xie X; Zhu Q; Liu J; Hu P; Qiu Q; Liang X; Zheng H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):777-81. PubMed ID: 26733134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
    Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
    Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the duplicate notifiable reporting of hepatitis B infection in Zhejiang province, China, 2005-2015.
    He H; Zhou Y; Xie S
    Vaccine; 2017 Aug; 35(36):4702-4706. PubMed ID: 28750855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sero-epidemiological analysis on hepatitis B among children aged 1-14 years old born to HBsAg positive mother in China, 2014].
    Wang FZ; Zheng H; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):457-461. PubMed ID: 28468062
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination.
    Zhang L; Xu A; Yan B; Song L; Li M; Xiao Z; Xu Q; Li L
    Int J Infect Dis; 2010 Jun; 14(6):e483-8. PubMed ID: 19939719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
    BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
    Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization.
    Liao XY; Zhou ZZ; Wei FB; Qin HN; Ling Y; Li RC; Li YP; Nong Y; Sun KX; Li J; Zhuang H
    Hum Vaccin Immunother; 2014; 10(1):224-31. PubMed ID: 24018404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis on sero-epidemiological characteristics of hepatitis B virus among people born during 1994-2001 before and after hepatitis B vaccine catch-up vaccination, China].
    Wang FZ; Zheng H; Miao N; Sun XJ; Zhang GM; Liang XF; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):469-474. PubMed ID: 28592087
    [No Abstract]   [Full Text] [Related]  

  • 19. World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.
    Diarra B; Yonli AT; Ouattara AK; Zohoncon TM; Traore L; Nadembega C; Obiri-Yeboah D; Yara J; Pietra V; Ouedraogo P; Bougouma A; Sanogo R; Simpore J
    Virol J; 2018 Aug; 15(1):121. PubMed ID: 30081915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.
    Yonghao G; Jin X; Jun L; Pumei D; Ying Y; Xiuhong F; Yanyang Z; Wanshen G
    Int J Infect Dis; 2015 Nov; 40():75-80. PubMed ID: 26456567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.